Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
![]() | UCB | 3 | - | +0,06 % | |
![]() | AB INBEV | 2 | 30 | -0,58 % | |
![]() | UMICORE | 2 | 2 | +1,28 % | |
ARGENX | 1 | 10 | +1,59 % | ||
![]() | AGEAS | 1 | 1 | -1,05 % | |
![]() | KBC GROEP NV | 1 | 1 | +0,55 % | |
![]() | GBL | 1 | 1 | +0,27 % | |
![]() | SOFINA | 1 | - | -1,55 % | |
![]() | MELEXIS | - | 4 | -0,84 % | |
![]() | ELIA GROUP | - | 4 | -1,42 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14:54 | UCB upgraded to "buy" as BofA raises Bimzelx sales forecast above consensus | 3 | Investing.com | ||
14:22 | CFRA stuft Umicore-Aktie auf "Halten" hoch nach verbessertem Ausblick für 2025 | 17 | Investing.com Deutsch | ||
14:18 | CFRA upgrades Umicore stock rating to Hold on improved 2025 guidance | 9 | Investing.com | ||
10:54 | UCB stock rating upgraded to Buy at BofA on Bimzelx growth potential | 1 | Investing.com | ||
10:46 | UCB-Aktie von BofA auf "Kaufen" hochgestuft dank Bimzelx-Wachstumspotenzial | 3 | Investing.com Deutsch | ||
10:14 | AB Inbev: Ein süffiges Investment: Mit hochpreisigen Premiummarken trotzt der weltgrösste ... | 5 | payoff.ch | ||
08:46 | KBC to launch crypto trading for retail investors | 1 | belga | ||
07:17 | ANHEUSER-BUSCH INBEV SA/NV - AB InBev reports on the progress of its share buy-back program announced on 31 October 2024 | 5 | SENS | ||
Di | GBL: GBL - Voting rights and denominator - Situation as at June 30, 2025 | 2 | Euronext | ||
Di | FDA weighs regulatory action on argenx's Vyvgart Hytrulo amid reports of 'severe worsening' of disease | 13 | FiercePharma | ||
Di | Sofina Foods expands in Europe with acquisition of Finnebrogue | 1 | Just Food | ||
Di | Ageas completes the acquisition of Saga's Underwriting Business | 208 | GlobeNewswire (Europe) | Ageas announced today that all necessary regulatory approvals for the acquisition of Acromas Insurance Company Limited (AICL), Saga's Underwriting Business, have been obtained and the transaction has... ► Artikel lesen | |
Di | Saga completes sale of insurance underwriting business to Ageas | 3 | Investing.com | ||
Di | UCB shares promising results for fenfluramine in ultra-rare form of epilepsy | - | PMLiVE | ||
Di | Argenx-Aktie steigt - H.C. Wainwright Kaufempfehlung bekräftigt | 8 | Investing.com Deutsch | ||
Di | Argenx stock advances as H.C. Wainwright reiterates Buy rating | 2 | Investing.com | ||
Di | Kurs der Anheuser-Busch NV-Aktie verharrt auf Vortags-Niveau (58,54 €) | 216 | ARIVA.de | Wenig Kursbewegung derzeit bei dem Anteilsschein von Anheuser-Busch NV . Zuletzt zahlten Investoren für die Aktie 58,54 Euro. Kaum auffällig ist aktuell am Aktienmarkt der Kurs von Anheuser-Busch NV.... ► Artikel lesen | |
Di | Syensqo bullish about specialty chemicals biz | 1 | China Daily | ||
Mo | argenx-Aktie fällt, während FDA Sicherheitssignal von Vyvgart Hytrulo prüft | 5 | Investing.com Deutsch | ||
Mo | argenx stock dips as FDA evaluates Vyvgart Hytrulo safety signal | 1 | Investing.com |